Antibiotics are a double-edged sword: they are crucial for treating ongoing infections, but they can also cause significant collateral damage to the microbiota (de Nies et al. Nat Rev Microbiol. 2023). Antibiotics supress the growth of commensal microorganisms and at the same time select for drug-resistance. Individuals are often benignly colonized with resistant potential pathogens persisting at low levels within their microbiota, such as extra-intestinal pathogenic Escherichia coli. Antibiotics can lead to overgrowth of these resistant pathogens, facilitating their spread within and between individuals (Stracy et al. Science. 2022). Antibiotics can also lead to resistance genes spreading between bacteria within the microbiota through various horizontal gene transfer mechanisms, such as conjugation. The behaviour of resistant strains and the level of horizontal gene transfer within the microbiota during treatment depends on the specific antibiotic, resistance mechanism, as well as the makeup of the other bacteria present in the microbiota.
This overall aim of this project is to answer the important questions:
To achieve this, we will use a combination of in vitro and in vitro experimental approaches with synthetic and human-derived microbial communities. Microscopy methods will be used to understand the effect of antibiotics on the micro-scale biogeography of the microbiota. We will test approaches to modify the microbiota to minimize antibiotic-induced pathogen overgrowth or horizontal gene transfer.
Stracy lab
Studying how bacteria respond to antibiotics from multiple perspectives; ranging from molecular biology to infection epidemiology
Available PhD projects
Over 30 groups work at the Dunn School to uncover the molecular and cellular mechanisms underlying disease. Discover which research groups are accepting students for our next round of applications.
How to Apply
Find out more on how to apply.